Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Drug News & Perspectives|December 24, 2004
Cytokines and IDDM: implications for etiology and therapyB Balasa, N SarvetnickCellular Immunology|May 1, 1993
Induction of experimental autoimmune thyroiditis in rats with the synthetic peptide (2495-2511) of thyroglobulinB Balasa, G CarayanniotisCellular Immunology|September 1, 1993
Immunotargeting of thyroglobulin on antigen presenting cells abrogates natural tolerance in the absence of adjuvantB Balasa, G CarayanniotisJournal of Autoimmunity|April 1, 1996
The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetesB Balasa, N SarvetnickCellular Immunology|May 1, 1999
Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic miceB Balasa, J Lee, N SarvetnickClinical Immunology (Orlando, Fla.)|April 26, 2000
The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetesB Balasa, K Van Gunst, N SarvetnickImmunogenetics|January 1, 1994
Mapping of thyroglobulin epitopes: presentation of a 9mer pathogenic peptide by different mouse MHC class II isotypesV P Rao, B Balasa, G CarayanniotisJournal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouseW S Gallichan, B Balasa, J D Davies, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravisB Balasa, C Deng, J Lee, et al.Cellular Immunology|July 18, 2000
IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouseB Balasa, K Van Gunst, N Jung, et al.Pageof 2